YAP1 and cholangiocarcinoma: However, in the context of CC, there are only a few small-scale studies that suggest a relationship between YAP1 and lymph node metastasis (87), and there is still a lack of large-scale quantitative clinical studies linking YAP1 or 11q22 amplification to FIGO stage, lymph node metastasis, and long-term patient outcomes.